We are live on ! Find out more
1CM

1492 Capital Management Portfolio holdings

AUM $263M
1-Year Est. Return 61.9%
This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$210M
AUM Growth
+$9.98M
Cap. Flow
+$2.18M
Cap. Flow %
1.04%
Top 10 Hldgs %
30.25%
Holding
124
New
24
Increased
26
Reduced
38
Closed
15

Top Buys

Rank Stock Value
1
KURA icon
Kura Oncology
KURA
+$3.88M
2
ADTN icon
Adtran
ADTN
+$2.69M
3
MXL icon
MaxLinear
MXL
+$2.38M
4
GXO icon
GXO Logistics
GXO
+$1.98M
5
SRAD icon
Sportradar
SRAD
+$1.89M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Industrials 19.67%
3 Healthcare 18.04%
4 Financials 15.4%
5 Consumer Discretionary 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRS icon
1
Carpenter Technology
CRS
$30B
$8.02M 3.81%
47,242
-19,114
-29% -$3.28M
JEF icon
2
Jefferies Financial Group
JEF
$12.9B
$7.63M 3.63%
97,285
-1,328
-1% -$95.5K
ZETA icon
3
Zeta Global
ZETA
$4.77B
$7.13M 3.39%
396,536
-4,353
-1% -$110K
STRL icon
4
Sterling Infrastructure
STRL
$20.3B
$6.67M 3.17%
39,603
-5,102
-11% -$881K
FOUR icon
5
Shift4
FOUR
$3.84B
$6.17M 2.94%
59,499
-1,516
-2% -$151K
GDYN icon
6
Grid Dynamics Holdings
GDYN
$476M
$6.03M 2.87%
270,995
-133,807
-33% -$2.34M
SF
7
Stifel
SF
$12.3B
$5.62M 2.67%
79,532
-987
-1% -$70.5K
LNTH icon
8
Lantheus
LNTH
$6.82B
$5.51M 2.62%
61,623
-522
-0.8% -$50.8K
IMAX icon
9
IMAX
IMAX
$2.38B
$5.41M 2.57%
211,252
-5,032
-2% -$118K
EHC icon
10
Encompass Health
EHC
$11.2B
$5.4M 2.57%
58,515
-575
-1% -$56.5K
MGNI icon
11
Magnite
MGNI
$2.65B
$5.22M 2.48%
327,775
-2,658
-0.8% -$39K
VBTX
12
DELISTED
Veritex Holdings
VBTX
$5.2M 2.47%
191,423
-1,514
-0.8% -$42.7K
CPA icon
13
Copa Holdings
CPA
$5.56B
$5.07M 2.41%
57,638
-634
-1% -$60.1K
SN icon
14
SharkNinja
SN
$21B
$5.01M 2.38%
51,409
-1,357
-3% -$138K
VRNA
15
DELISTED
Verona Pharma
VRNA
$4.64M 2.21%
100,002
-61,053
-38% -$2.29M
GENI icon
16
Genius Sports
GENI
$1.73B
$4.5M 2.14%
520,661
-4,367
-0.8% -$36.5K
ITCI
17
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.39M 2.09%
52,537
-322
-0.6% -$26.5K
HQY icon
18
HealthEquity
HQY
$7.91B
$4.36M 2.07%
45,394
-445
-1% -$41.5K
WNS
19
DELISTED
WNS Holdings
WNS
$4.13M 1.96%
87,048
+7,594
+10% +$375K
DCGO icon
20
DocGo
DCGO
$58.9M
$3.59M 1.71%
847,479
-5,833
-0.7% -$22.5K
NPKI
21
NPK International
NPKI
$1.21B
$3.41M 1.62%
444,305
-6,894
-2% -$50.7K
STC icon
22
Stewart Information Services
STC
$2.05B
$3.37M 1.6%
49,996
-1,069
-2% -$76.4K
PRIM icon
23
Primoris Services
PRIM
$4.69B
$3.35M 1.59%
43,823
-19,660
-31% -$1.44M
CAKE icon
24
Cheesecake Factory
CAKE
$4.21B
$3.33M 1.58%
70,123
-775
-1% -$35.7K
MNKD icon
25
MannKind Corp
MNKD
$1.28B
$3.11M 1.48%
483,600
-11,225
-2% -$75.3K

Similar funds

1492 Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, 1492 Capital Management held 124 positions worth $210M, up 5% from $200M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

1492 Capital Management's Q4 2024 filing shows 24 new, 26 increased, 38 reduced and 15 closed positions. Its largest new stake was Adtran: 364,056 shares worth $3.03M. The largest sale was Exact Sciences, an estimated $5.64M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

  • 1492 Capital Management's largest Q4 2024 buy was Adtran: 364,056 shares worth $3.03M.
  • 1492 Capital Management added most to Kura Oncology in Q4 2024, an estimated $3.88M increase.
  • 1492 Capital Management's biggest Q4 2024 reduction was Carpenter Technology, cutting an estimated $3.28M.
  • 1492 Capital Management fully exited Exact Sciences in Q4 2024, selling an estimated $5.64M.
  • 1492 Capital Management's ten largest holdings make up 30% of its $210M portfolio in Q4 2024.
  • 1492 Capital Management opened 24 new positions and closed 15 in Q4 2024.
  • 1492 Capital Management's portfolio value rose 5% quarter-over-quarter to $210M.

Based on 1492 Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.